Cargando…

Identifying and Targeting Prediction of the PI3K-AKT Signaling Pathway in Drug-Induced Thrombocytopenia in Infected Patients Receiving Linezolid Therapy: A Network Pharmacology-Based Analysis

The pharmacological mechanisms underlying the adverse effects of linezolid on thrombocytopenia have not been conclusively determined. This network pharmacology study aimed at investigating the potential pharmacological mechanisms of linezolid-induced adverse reactions in thrombocytopenia. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Jiao, Chen, Hongli, Li, Youjia, Liu, Chenwei, Zheng, Xiaowei, Feng, Siping, Wang, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588367/ https://www.ncbi.nlm.nih.gov/pubmed/36285187 http://dx.doi.org/10.1155/2022/2282351

Ejemplares similares

Linezolid vs Vancomycin in Induced Thrombocytopenia
por: Al-Harbi, Dimah, et al.
Publicado: (2022)

Potentially Hazardous Drug-Drug Interactions Associated With Oral Antineoplastic Agents Prescribed in Chinese Tertiary Care Teaching Hospital Settings: A Multicenter Cross-Sectional Study
por: Wang, Haitao, et al.
Publicado: (2022)

Comparative evaluation of thrombocytopenia in adult patients receiving linezolid or glycopeptides in a respiratory intensive care unit
por: ZHANG, ZHAORUI, et al.
Publicado: (2014)

Risk factors for linezolid-associated thrombocytopenia in adult patients
por: Natsumoto, B., et al.
Publicado: (2014)

Risk factors for linezolid-induced thrombocytopenia in adult inpatients
por: Han, Xiaonian, et al.
Publicado: (2021)

Effect of linezolid on platelet count in critically ill patients with thrombocytopenia
por: Tatsumi, Hiroomi, et al.
Publicado: (2023)

Effect of Platelet Parameters on Linezolid-Related Thrombocytopenia in Hospitalized Patients
por: Zhang, Lu, et al.
Publicado: (2023)

Gene mutations in the PI3K/Akt signaling pathway were related to immune thrombocytopenia pathogenesis
por: Ruan, Jing-Shu, et al.
Publicado: (2023)

Lactic Acidosis and Thrombocytopenia Associated with Linezolid Therapy: A Case Report
por: Xiao, Bing, et al.
Publicado: (2018)

Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients
por: Kawasuji, Hitoshi, et al.
Publicado: (2021)

Nomogram prediction model called “ADPLCP” for predicting linezolid-associated thrombocytopenia in elderly individuals
por: Liu, Yanxin, et al.
Publicado: (2023)

Hyperhomocysteinemia inhibits tibial fracture healing in rats through PI3K/AKT signaling pathway
por: Liu, Su, et al.
Publicado: (2020)

Mechanism Underlying Linezolid-induced Thrombocytopenia in a Chronic Kidney Failure Mouse Model
por: Nishijo, Nao, et al.
Publicado: (2017)

Association of Linezolid With Risk of Serotonin Syndrome in Patients Receiving Antidepressants
por: Bai, Anthony D., et al.
Publicado: (2022)

Chuanxiong improves angiogenesis via the PI3K/AKT/Ras/MAPK pathway based on network pharmacology and DESI-MSI metabolomics
por: Cheng, Xue-hao, et al.
Publicado: (2023)

The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
por: Basile, Maria Sofia, et al.
Publicado: (2022)

The PI3K/AKT pathway in obesity and type 2 diabetes
por: Huang, Xingjun, et al.
Publicado: (2018)

Efficacy of linezolid on gram-positive bacterial infection in elderly patients and the risk factors associated with thrombocytopenia
por: Bi, Li-qing, et al.
Publicado: (2013)

Reversible recurrent profound thrombocytopenia due to linezolid in a patient with multi-drug resistant tuberculosis: A case report
por: Wang, Ming-Gui, et al.
Publicado: (2018)

Pharmacologic concentrations of linezolid modify oxidative phosphorylation function and adipocyte secretome
por: Llobet, Laura, et al.
Publicado: (2017)

Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
por: Dong, Chao, et al.
Publicado: (2021)

Renal replacement therapy and concurrent fluconazole therapy increase linezolid-related thrombocytopenia among adult patients
por: Hsu, Yueh-Chun, et al.
Publicado: (2022)

Prevalence and risk factors for severe linezolid-associated thrombocytopenia in pediatric patients: An analysis of a public database
por: Yang, Shibo, et al.
Publicado: (2023)

Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway
por: Wang, Xuyang, et al.
Publicado: (2019)

The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway
por: Li, Meng, et al.
Publicado: (2021)

Celastrol Alleviates Autoimmune Hepatitis Through the PI3K/AKT Signaling Pathway Based on Network Pharmacology and Experiments
por: Wang, Shuhui, et al.
Publicado: (2022)

Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment
por: Lin, Anqi, et al.
Publicado: (2022)

Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway
por: Tu, Haitao, et al.
Publicado: (2021)

Screening of PI3K-Akt-targeting Drugs for Silkworm against Bombyx mori Nucleopolyhedrovirus
por: Wang, Bingbing, et al.
Publicado: (2019)

Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K
por: Yudushkin, Ivan
Publicado: (2019)

HijAkt: The PI3K/Akt Pathway in Virus Replication and Pathogenesis
por: Dunn, Ewan F., et al.
Publicado: (2012)

A retrospective cohort study to screen linezolid-induced thrombocytopenia in adult patients hospitalized in the Midwestern Region of Brazil
por: Lima, Letícia Souza, et al.
Publicado: (2020)

PI3K/AKT Pathway and Brain Malformations
por: Rice, Gavin B., et al.
Publicado: (2015)

PI3K and AKT: Unfaithful Partners in Cancer
por: Faes, Seraina, et al.
Publicado: (2015)

The PI3K/Akt Pathway in Meta-Inflammation
por: Acosta-Martinez, Maricedes, et al.
Publicado: (2022)

Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092
por: Yu, Yi, et al.
Publicado: (2015)

Hedysarum multijugum Maxim treats ulcerative colitis through the PI3K-AKT and TNF signaling pathway according to network pharmacology and molecular docking
por: Zhang, Zihao, et al.
Publicado: (2022)

Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy
por: Brown, Ashley N., et al.
Publicado: (2015)

Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San
por: Zhang, Shan, et al.
Publicado: (2021)

PI3K-Akt signaling pathway based on network pharmacology for the anti-Alzheimer’s disease effect of licorice stem flavonoids
por: Pei, Hongyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kbhec0jmtlga75gchto64t4ghf